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EX19 is a chaperone and import receptor for newly
synthesized, class I peroxisomal membrane proteins
(PMPs). PEX19 binds these PMPs in the cytoplasm and
delivers them to the peroxisome for subsequent insertion
into the peroxisome membrane, indicating that there may
be a PEX19 docking factor in the peroxisome membrane.
Here we show that PEX3 is required for PEX19 to dock at
peroxisomes, interacts speciﬁcally with the docking domain
of PEX19, and is required for recruitment of the PEX19
P
 
docking domain to peroxisomes. PEX3 is also sufﬁcient to
dock PEX19 at heterologous organelles and binds PEX19
via a conserved motif that is essential for this docking
activity and for PEX3 function in general. Not surprisingly,
transient inhibition of PEX3 abrogates class I PMP import
but has no effect on class II PMP import or peroxisomal
matrix protein import. Taken together, these results suggest
that PEX3 plays a selective, essential, and direct role in
PMP import as a docking factor for PEX19.
 
Introduction
 
Peroxisomes are single membrane organelles present in
nearly all free-living eukaryotes. The biogenesis of peroxi-
somes requires a group of protein factors referred to as
peroxins and the 
 
PEX
 
 genes that encode them (Distel et al.,
1996; Sacksteder and Gould, 2000). A variety of studies
have demonstrated that all, or nearly all, peroxisomal proteins
are synthesized on free polyribosomes and imported post-
translationally (Lazarow and Fujiki, 1985). Peroxisomal ma-
trix enzymes typically possess a peroxisomal targeting signal
(PTS1 or PTS2; Gould et al., 1989; Swinkels et al., 1991)
and their import is dependent upon the predominantly
cytoplasmic PTS1 and PTS2 receptors (PEX5 and PEX7,
respectively; McCollum et al., 1993; Marzioch et al., 1994;
Dodt et al., 1995; Wiemer et al., 1995), receptor docking
factors on the peroxisome membrane (PEX14 and PEX13;
Elgersma et al., 1996; Erdmann and Blobel, 1996; Gould et
al., 1996; Albertini et al., 1997; Girzalsky et al., 1999; Stein
et al., 2002) and a host of other peroxins of ill-defined function
(Sacksteder and Gould, 2000; Gould and Collins, 2002).
Like their cousin enzymes, PMPs are also imported by a
direct cytoplasm-to-peroxisome mechanism, as suggested by
kinetic studies in vivo (Fujiki et al., 1984; Imanaka et al.,
1996) and the ability of peroxisomes to import newly syn-
thesized PMPs directly from cytosolic lysates (Diestelkotter
and Just, 1993; Pause et al., 1997). However, PMPs use differ-
ent types of signals (PMP targeting signals [mPTSs]; Dyer et
al., 1996; Jones et al., 2001, 2004) and are imported inde-
pendently of the peroxins involved in matrix protein import
(Chang et al., 1999a; Hettema et al., 2000).
Two pathways of PMP import have been described (Jones
et al., 2004). The class I pathway of PMP import is dependent
upon PEX19, which binds a wide variety of PMPs (Gloeckner
et al., 2000; Sacksteder et al., 2000; Snyder et al., 2000;
Fransen et al., 2001; Brosius et al., 2002), and then binds
their transmembrane domains, stabilizes them during their
transit through the cytoplasm, and releases them before or
during their insertion into the peroxisome membrane (Jones
et al., 2004). PEX19 also binds to the targeting signals (mPTSs)
of numerous class I PMPs (Jones et al., 2001, 2004; Bro-
sius et al., 2002), is required for class I mPTS function in
vivo, and is essential for the import of class I PMPs, though
it is not required for import of peroxisomal matrix enzymes
or a class II PMP (Jones et al., 2004). Taken together, these
results indicate that PEX19 is a cytoplasmic chaperone and
import receptor for newly synthesized class I PMPs.
The class I PMPs are a diverse group and include metabolite
transporters such as PMP22, PMP34, and PMP70, peroxins
involved in peroxisome division such as PEX11, peroxins
involved in peroxisomal matrix protein import such as
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PEX2 and PEX13, and even one peroxin involved in peroxi-
some membrane synthesis, PEX16 (Sacksteder et al., 2000;
Jones et al., 2001, 2004; Brosius et al., 2002). In fact, the
only PMP that is known to be imported independently of
PEX19 is PEX3, which currently defines the class II PMP
import pathway (Jones et al., 2004).
The observation that PEX19 binds newly synthesized class
I PMPs in the cytoplasm and then transports them to the
peroxisome indicates that there is at least one docking factor
for PEX19 on the peroxisome membrane. A docking factor
for PEX19 can be expected to have certain properties. For
example, it must bind to PEX19 and it must reside in the
peroxisome membrane. However, these properties are also
shared by all integral PMPs that depend on PEX19 for their
import (Sacksteder et al., 2000; Jones et al., 2004). More
stringent criteria for the PEX19 docking factor are necessary
and some are as follows. First, loss of a putative docking fac-
tor must block the recruitment of PEX19 to peroxisomes.
Second, a docking factor should interact with a region of
PEX19 that (a) differs from its PMP-binding domain, (b) is
sufficient for docking, and (c) requires the docking factor for
its recruitment to peroxisomes. Third, mislocalization of a
PEX19 docking factor to another organelle should be suffi-
cient to dock PEX19 at the heterologous organelle. Fourth,
the docking factor for PEX19 should be required for class I
PMP import but dispensable for class II PMP import and
peroxisomal matrix protein import. Here we show that
PEX3 meets all of these criteria.
 
Results
 
PEX3 is required for PEX19 docking
 
Aside from PEX19, only one conserved peroxin, PEX3, is
known to be required for peroxisome membrane biogenesis
(PEX16 is required for peroxisome membrane biogenesis in
mammalian cells [Honsho et al., 1998; South and Gould,
1999], but is absent from the yeast 
 
Saccharomyces cerevisiae
 
and serves a different function in the yeast 
 
Yarrowia lipo-
lytica
 
 [Eitzen et al., 1997]). Human and yeast cells lacking
the 
 
PEX3
 
 gene are devoid of detectable peroxisomes, rapidly
degrade most PMPs, and mislocalize other PMPs to the mi-
tochondria and other organelles (Chang et al., 1999a; Het-
tema et al., 2000; South et al., 2000). Thus, of the known
peroxins, PEX3 represents an obvious candidate for a
PEX19 docking factor.
To determine whether PEX3 is required for PEX19 to
dock at the peroxisome membrane we tested whether tran-
sient depletion of PEX3, using RNA interference (RNAi)
technology, affected PEX19’s association with peroxisomes.
Wild-type (WT) human fibroblasts transfected with small
interfering RNAs (siRNAs) specific for the 
 
PEX3
 
 gene show
a significant reduction in PEX3 protein levels at 2–3 d after
Figure 1. The effect of PEX3 on the localization of 3xHA-PEX19. (A) GM5756-TI 
cells were transfected with TRIP8bsiRNAs, PEX3siRNAs, or PEX5siRNAs, respectively. 
Cells were lysed each day following the siRNA treatment, and equivalent amounts 
of protein from each sample were processed for immunoblot with antibodies 
against PEX3 and PEX5. (B) On day 2 after the siRNA treatment, cells were processed 
for double indirect immunofluorescence microscopy with anti-PEX3 and anti-PMP70 antibodies. (C and D) 3xHA-PEX19/PBD399-TI cells 
(untreated) and 3xHA-PEX19/PBD399-TI cells transfected with TRIP8bsiRNAs or PEX3siRNAs were grown for 2 d and processed for double 
indirect immunofluorescence microscopy with antibodies against (C) the HA epitope and PEX3, or (D) the HA epitope and PMP70. Bars, 20  m. 
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transfection, with levels reduced 
 
 
 
90% on day 2 (Fig. 1 A).
At this time point, PEX3 can no longer be detected on per-
oxisomes by immunofluorescence (Fig. 1 B). Control RNAi
directed against 
 
TRIP8b
 
 (a gene that has no role in peroxi-
some biogenesis; Chen et al., 2001) or 
 
PEX5
 
 (a gene that
functions only in peroxisomal matrix protein import; Dodt
et al., 1995; Chang et al., 1999a) had no effect on PEX3
abundance within the cell.
Although PEX19 is partly peroxisomal, the vast majority
of PEX19 is located in the cytoplasm and we have been un-
able to detect appreciable levels of WT PEX19 on peroxi-
somes either by subcellular fractionation or by immunofluo-
rescence microscopy (Sacksteder et al., 2000). However, the
Fujiki lab has reported that an NH
 
2
 
-terminally tagged form
of PEX19 can be detected on peroxisome membranes (Mat-
suzono et al., 1999) and we therefore used a 3xHA-PEX19
fusion protein to assess PEX19 docking in the presence or
absence of PEX3. 3xHA-PEX19 is detected easily on peroxi-
somes though the cytoplasmic pool of the protein is also sig-
nificant (Fig. 1 C). In contrast, 3xHA-PEX19 cannot be de-
tected on peroxisomes in cells that were cotransfected with
the 
 
PEX3
 
 siRNAs and lack PEX3 protein. The absence of
peroxisome-associated 3xHA-PEX19 is not due to a com-
plete absence of peroxisomes from 
 
PEX3
 
-depleted cells,
since they still contain peroxisome-associated PMP70 (Fig. 1
D). The requirement for PEX3 also appears specific, as
3xHA-PEX19 colocalizes with peroxisomes in human fibro-
blasts from peroxisome biogenesis disorder patients (Gould
and Valle, 2000) that carry inactivating mutations in the
 
PEX1
 
, 
 
PEX2
 
, 
 
PEX5
 
, 
 
PEX6
 
, 
 
PEX7
 
, 
 
PEX10
 
, 
 
PEX12
 
, 
 
PEX13
 
,
and 
 
PEX26
 
 genes, as well as in WT cells that are depleted for
 
PEX16
 
 by RNAi (Fig. 2).
 
The docking domain of PEX19 binds to PEX3
 
As a chaperone and import receptor for newly synthesized
class I PMPs, PEX19 is likely to use distinct domains for
binding these ligands and for docking with the peroxisome
membrane. We constructed a series of deletion mutants in
PEX19 and assayed these for docking to peroxisomes. A
fragment consisting of just the NH
 
2
 
-terminal 56 amino ac-
ids of PEX19 is sufficient for docking to peroxisomes but is
unable to bind class I PMPs, whereas the remainder of the
protein, amino acids 57–299, retains the ability to bind nu-
merous class I PMPs but is unable to dock at peroxisomes
(Fig. 3). Previous studies have established that this same seg-
ment of PEX19 is sufficient to bind PEX3 (Snyder et al.,
2000; Fransen et al., 2001), which we show again here (Fig.
3, bottom four panels). Thus, the same short region of
PEX19 that binds to PEX3 is also sufficient for docking
PEX19 at the peroxisome membrane.
The preceding results indicate that PEX3 might function
as a docking factor for PEX19. If this hypothesis is correct,
transient reduction of PEX3 levels should block recruitment
of the PEX19 docking domain to peroxisomes. To test this
we examined the subcellular distribution of PEX19aa1–56
in human fibroblasts transfected with control and PEX3 si-
Figure 2. The localization of 3xHA-PEX19 in other human pex mutants. Human fibroblasts from peroxisome biogenesis disorder patients 
that carry inactivating mutations in the PEX1, PEX2, PEX5, PEX6, PEX7, PEX10, PEX12, PEX13, and PEX26 genes were transfected with 3xHA-PEX19 
expression plasmid, grown overnight, and processed for indirect immunofluorescence microscopy with anti-HA and anti-PMP70 antibodies. 
GM5756-TI cells were also transfected with PEX16siRNAs and the 3xHA-PEX19 expression plasmid. 2 d after the transfection, at a time when 
PEX16 activity is impaired (unpublished data), these cells (PEX16-) were subjected to double indirect immunofluorescence microscopy using 
anti-HA and anti-PMP70 antibodies. Bar, 20  m. 
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RNAs. Control siRNA had no affect on PEX3 abundance
and did not affect the association of the PEX19 docking do-
main with peroxisomes (Fig. 4, A and B). In contrast, cells
that had reduced levels of PEX3 protein (after transfection
with PEX3 siRNAs) were unable to recruit the PEX19 dock-
ing domain to peroxisomal membranes (Fig. 4, C–F).
 
A conserved peptide motif of PEX3 binds PEX19 and is 
required for PEX19 docking
 
Another way to assess the possibility that PEX3 is a PEX19
docking factor is to identify a region of PEX3 that binds
to PEX19 and then determine whether it is important for
PEX19 docking. To identify a PEX19-binding site within
PEX3 we assayed a series of PEX3 protein fragments for their
ability to interact with PEX19 in vivo. Segments of the PEX3
protein were coexpressed with 3xNLS-PEX19 (Jones et
al., 2001) in human fibroblasts, followed by immunofluo-
rescence microscopy to determine whether 3xNLS-PEX19
bound the fragments well enough to concentrate them in the
nucleus (Fig. 5, A–E). These studies revealed the existence
of a conserved, 17–amino acid-long segment of human
PEX3, amino acids 120–136 (NH
 
2
 
-YSTCMLVVLLRVQL-
NII-COOH), which is sufficient for binding to PEX19 in
vivo.
To determine whether this region of PEX3 is important
for PEX3 function and for PEX19 docking, we first created
a mutant version of PEX3 altered in this region. This motif
is predicted to have a strong 
 
 
 
-helical propensity. To disrupt
this motif we replaced a conserved leucine near the NH
 
2
 
 ter-
minus of the motif with a proline (L125P), as well as a con-
served asparagine with an aspartate (N134D). This mutant
PEX3 protein no longer interacted with PEX19 (as evident
from its lack of colocalization with 3xNLS-PEX19; Fig. 5,
F–I), no longer complemented 
 
PEX3
 
-deficient human cells
(unpublished data), but was still properly targeted to peroxi-
somes in WT human fibroblasts (Fig. 5, J–M).
The mislocalization of PEX3 to other subcellular or-
ganelles in cells that lack PEX19 (and therefore lack peroxi-
somes) makes it possible to ask whether PEX3 is sufficient to
recruit PEX19 to organelle surfaces. PEX19-deficient cells
were cotransfected with plasmids designed to express the
docking domain of PEX19 (3xHA-PEX19aa1–56) and ei-
Figure 3. Characterization of the docking 
domain of PEX19. (A–D) GM5756-TI 
cells were transfected with (A and B) the 
3xHA-PEX19aa1–56 or (C and D) 3xHA-
PEX19aa57–299 expression plasmids, 
respectively, grown overnight and 
processed for double indirect immuno-
fluorescence using (A and C) anti-HA 
and (B and D) anti-PMP70 antibodies. 
(E) PBD399-TI cells were cotransfected 
with the plasmids designed to express 
either 3xNLS-PEX19aa1–56–3xHA or 
3xNLS-PEX19aa57–299–3xHA, together 
with plasmids designed to express 
PMP22aa1–94–3xmyc, PMP34aa244–
307–3xmyc, PEX16aa221–336–3xmyc, 
and PEX3–3xmyc. 24 h after the trans-
fection, cells were processed for double 
indirect immunofluorescence using anti-
HA and anti-myc antibodies. Bars, 20  m. 
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ther WT PEX3–3xmyc or the L125P/N134D mutant form
of PEX3–3xmyc. Both PEX3 proteins are imported into
heterologous organelles, including mitochondria and small
unidentifiable small vesicles. WT PEX3 is able to recruit the
docking domain of PEX19 to these other organelles (Fig. 6,
A and B) but the L125P/N134D mutant form of PEX3myc
is unable to recruit the docking domain of PEX19 to these
organelles (Fig. 6, C and D).
 
PEX3 is required for PMP import
 
The observation that PEX3 is both necessary and sufficient to
mediate PEX19 docking indicates that it should also be es-
sential for class I PMP import. To test this we again used
PEX3 RNAi to generate a transient depletion of PEX3 pro-
tein in cells that still possessed peroxisomes. We also used
control RNAi specific for the 
 
TRIP8b
 
 and 
 
PEX5
 
 transcripts
(please refer to Fig. 1 for control immunoblots). 3 d after
transfection with the RNAi, the cells from each population
were retransfected with a pair of plasmids designed to express
(a) an HA-tagged peroxisomal matrix protein (HA-PTE1;
Jones et al., 1999) and (b) any of several myc-tagged PMPs.
These included the class I PMPs PMP34 (PMP34myc),
PEX11
 
 
 
 (PEX11
 
 
 
myc) and a PEX16 mPTS, as well as a
class II PMP, the mPTS of PEX3 (Jones et al., 2004). At 2 h
 
after the DNA transfection, the cells were fixed and processed
for immunofluorescence microscopy using antibodies specific
for the matrix and membrane marker proteins.
These experiments revealed that inhibition of PEX3 in-
duced a selective defect in import of class I PMPs but had no
detectable effect on the import of a class II PMP or a peroxi-
somal matrix protein (Fig. 7). In addition to the immuno-
fluorescence microscopy images, which provide a visual rep-
resentation of these results (Fig. 7 A), we assessed import
capabilities of hundreds of randomly selected cells from each
population. The statistical analysis of this data confirms that
inhibition of PEX3 resulted in a specific defect in class I
PMP import (Fig. 7, B–D).
 
Yeast PEX3 also plays a selective role in PMP import
 
PEX3 is also required for peroxisome membrane synthesis
in the yeast 
 
S. cerevisiae
 
, as evident from the rapid destruc-
tion of PMPs and lack of peroxisomal membranes in 
 
pex3
 
-
null mutants of this yeast (Hettema et al., 2000). To test
whether yeast PEX3 also plays a selective and essential role
in PMP import we first sought to generate temperature-sen-
sitive 
 
pex3
 
 mutants of this yeast. These experiments used a
 
pex3
 
 
 
 derivative of the strain BY4733 (Baker-Brachmann et
al., 1998), YFY1, that also carries a 
 
LEU2
 
-containing plas-
mid that constitutively expresses CFP-PTS1 (a cyan fluo-
rescing form of green fluorescent protein (CFP) that con-
tains a type 1 peroxisomal-targeting signal at its COOH
terminus and is imported into the peroxisome lumen (Ka-
lish et al., 1996)). In YFY1, CFP-PTS1 accumulates in the
cytoplasm instead of being targeted to peroxisomes, though
it is imported into peroxisomes in YFY1 cells that carry the
WT 
 
PEX3
 
 gene on a plasmid (unpublished results). To
obtain temperature-sensitive 
 
pex3
 
 mutants, YFY1 cells
were cotransformed with (a) a 
 
PEX3
 
 gap repair plasmid
(pRS314-scPEX3UTR) that contained the 
 
PEX3
 
 promoter
and 3
 
 
 
-flanking regions but lacked all 
 
PEX3
 
 coding se-
quences and (b) a PCR-generated 
 
PEX3
 
 DNA fragment
that contained the entire 
 
PEX3
 
 gene, including about 100
bps of flanking sequences on either side of the 
 
PEX3
 
 ORF.
1,000 transformants were spotted onto duplicate plates, in-
cubated at 25
 
 
 
 and 37
 
 
 
C for 3 d, and then examined by epi-
fluorescence microscopy to determine the subcellular distri-
bution of CFP-PTS1. Three conditional 
 
pex3
 
 mutants were
identified, each of which imported CFP-PTS1 at the per-
missive temperature (25
 
 
 
C) but accumulated CFP-PTS1 in
the cytoplasm at the restrictive temperature (37
 
 
 
C): 
 
pex3
 
-
A8, 
 
pex3
 
-B5, and 
 
pex3
 
-G6 (Fig. 8).
The 
 
PEX3
 
-expression plasmids were recovered from each of
the three yeast strains, transformed into bacteria, and ampli-
fied. After their reintroduction into YFY1 cells, all three plas-
mids again conferred a temperature-sensitive 
 
pex3
 
 phenotype,
demonstrating that the conditional phenotypes of the 
 
pex3
 
-
A8, 
 
pex3
 
-B5, and 
 
pex3
 
-G6 strains mapped to their plasmid-
borne 
 
pex3
 
 genes. The sequences of the 
 
pex3
 
 alleles carried on
these plasmids were determined and each contained several
amino acid substitutions: Y144N, T161S, T261A, and
N430Y for 
 
pex3
 
-A8; E132G, K369N, T398S for 
 
pex3
 
-B5;
L11Q, Q248P, F275Y, L305F, and D415V for 
 
pex3
 
-G6.
To determine whether PEX3 played essential roles in PMP
import, peroxisomal matrix protein import, or both, we as-
Figure 4. The effect of PEX3 depletion on the localization of the 
PEX19 docking domain. GM5756-TI cells were cotransfected with a 
plasmid designed to express 3xHA-PEX19aa1–56 and siRNAs specific 
for either (A and B) TRIP8b or (C–F) PEX3. On day 2 after transfection, 
cells were processed for double indirect immunofluorescence 
microscopy with (A and C) anti-HA antibody and (B and D) anti-PEX3 
antibodies. The same samples were also processed for double indirect 
immunofluorescence assay with (E) anti-HA and (F) anti-PMP70 
antibodies. Bar, 20  m. 
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sayed both processes in YFY1 cells carrying either a WT
 
PEX3
 
 expression plasmid or the 
 
pex3
 
-G6 plasmid, which ap-
peared to confer the “tightest” conditional phenotype of the
three mutant plasmids we obtained. These two strains, which
constitutively express CFP-PTS1, were then transformed, in-
dividually, with plasmids that carried the galactose-inducible
 
GAL1
 
 promoter driving the expression of four peroxisomal
marker proteins: (a) YFP-PTS1, a peroxisomal matrix protein
(Kalish et al., 1996), (b) YFP-PEX10, a YFP-tagged form of a
PMP that is involved in peroxisome biogenesis (Kalish et al.,
1995), (c) YFP-PEX15, another YFP-tagged form of a PMP
that is involved in peroxisome biogenesis (Elgersma et al.,
1997), and (d) ANT1-YFP, a YFP-tagged form of a PMP
that is involved in ATP translocation across the peroxisome
membrane and plays no role in peroxisome biogenesis (Pal-
mieri et al., 2001). The resulting strains were grown at the
permissive temperature in minimal glucose medium to re-
press expression of the YFP marker proteins. Each strain was
then transferred to galactose medium to induce expression of
the YFP marker proteins and either maintained at the per-
missive temperature or shifted to the restrictive temperature.
4 h after the temperature shift the cells were fixed and exam-
Figure 5. Characterization of one PEX19-interacting motif of PEX3. (A) Selected segments of PEX3 tagged with 3xmyc were coexpressed in 
PBD399-TI cells with either 3xNLS-PEX19 or 3xNLS-HAOX3 followed by double indirect immunofluorescence microscopy. The interaction 
strength was calculated by counting cells in which PEX3 segments accumulated in the nucleus (    ,  80% cells concentrated the PEX3 
segment in the nucleus;    , 60–79%;   , 40–59%;  , 15–39%;  / ,  15%;  , 0%). (B–E) PBD399-TI cells were cotransfected with 
plasmids to express (B, C) 3xmyc-PEX3aa120–136 and 3xNLS-PEX19, or (D, E) 3xmyc-PEX3aa120–136 and 3xNLS-HAOX3. 24 h after the 
transfection, cells were processed for double indirect immunofluorescence microscopy with (B) anti-PEX19 and (C) anti-myc antibodies, or 
(D) anti-HAOX3 and (E) anti-myc antibodies. (F–I) PBD399-TI cells were cotransfected with plasmids designed to express (F and G) 3xNLS-PEX19 
and PEX3L125P/N134D-3xmyc, or (H and I) 3xNLS-PEX19 and PEX3–3xmyc, grown overnight, and processed for double indirect immuno-
fluoresence microscopy with (F and H) anti-PEX19 and (G and I) anti-myc antibodies. (J–M) GM5756-TI cells were transfected with (J and K) 
pcDNA3-PEX3L125P/N134D-3xmyc or (L and M) pcDNA3-PEX3–3xmyc, respectively, and grown overnight. The localization of PEX3L125P/
N134D-3xmyc and PEX3–3xmyc was examined by double indirect immunofluoresence with antibodies against (J and L) the myc epitope and 
(K and M) endogenously expressed PMP70. Bar, 20  m.
Figure 6. The effect of PEX3L125P/N134D on PEX19 docking. 
PBD399-TI cells were cotransfected with (A and B) pcDNA3–3xHA-
PEX19aa1–56 and pcDNA3-PEX3–3xmyc or (C and D) pcDNA3–
3xHA-PEX19aa1–56 and pcDNA3-PEX3L125P/N134D-3xmyc, 
grown overnight, and processed for double indirect immunofluores-
cence microscopy using (A and C) anti-myc and (B and D) anti-HA 
antibodies. Bar, 20  m.PEX3 acts as a docking factor in PMP import | Fang et al. 869
ined by epifluorescence microscopy to determine the subcel-
lular distribution of the proteins as marked by CFP and YFP.
As expected, YFY1 cells containing the WT PEX3 gene im-
ported both YFP-PTS1 and the YFP-PMP fusion proteins
into peroxisomes at both the permissive and restrictive tem-
peratures (Fig. 9 A). The temperature-sensitive pex3-G6
strain also imported all four peroxisomal marker proteins at
the permissive temperature. However, when the pex3-G6
strain was shifted to 37 C, it was unable to import YFP-
PEX10, ANT1-YFP, or YFP-PEX15 proteins into peroxi-
somes, even though it continued to import the peroxisomal
matrix protein marker YFP-PTS1 (Fig. 9 B). Similar results
Figure 7. The effect of PEX3 depletion on class I and II PMP import. (A) GM5756-TI cells were electroporated with PEX3, TRIP8b, or PEX5 
siRNAs, respectively, grown for 2–3 d, retransfected with a pair of plasmids designed to express (a) HA-PTE1 and (b) each of the following 
myc-tagged proteins: PMP34myc, PEX11 myc, the mPTS of PEX16 (PEX16aa221–336–3xmyc), and PEX3(PEX3aa1–50–6xmet3xmyc). 
2 h later, cells were processed for double indirect immunofluoresence microscopy with antibodies against the HA and myc epitopes. Bar, 20  m. 
(B–D) Cells showing peroxisomal staining (import of either marker) were counted as to whether they imported HA-PTE1 only (matrix only), 
PMPs-myc only (membrane only), or both (both) in the populations transfected with (B) PEX3siRNAs, (C) TRIP8bsiRNAs, and (D) PEX5siRNAs. 
Each experiment was done in triplicate and the mean and standard deviation are presented.870 The Journal of Cell Biology | Volume 164, Number 6, 2004
were obtained in the pex3-A8 and pex3-B5 strains (Fig. 10).
Thus, transient inhibition of yeast PEX3 results in a specific
defect in PMP import with no apparent defect in peroxi-
somal matrix protein import. Previous studies have also re-
ported variable and aberrant fates for PMPs in cells that lack
PEX3 activity (Hettema et al., 2000; South et al., 2000), and
these are reflected in our inability to detect YFP-PEX10 and
YFP-PEX15 and the mislocalization of ANT1-YFP to non-
peroxisomal structures in cells that lack PEX3 activity.
Discussion
In a recent study we established that there are at least two
mechanistically distinct pathways of PMP import, a class I
pathway that is dependent upon PEX19 and a class II path-
way that is independent of PEX19 (Jones et al., 2004). Here
we observed that PEX3 is essential for PEX19 docking at
peroxisomes and sufficient to dock PEX19 at heterologous
membranes. The PEX3-binding domain of PEX19 is suffi-
cient for docking PEX19 at the peroxisome surface, but only
in the presence of PEX3 on the peroxisome surface. Disrup-
tion of the PEX19-binding site on PEX3 disrupts its ability
to recruit PEX19 to membranes and eliminates PEX3 func-
tion. Finally, we show that PEX3 is essential for import of
class I PMPs but is not required for either class II PMP im-
port or peroxisomal matrix protein import. These observa-
tions support the hypothesis that PEX3 plays an essential
and selective role in the import of class I PMPs and that this
role includes being a docking factor for PEX19, the class I
PMP import receptor. It is also consistent with the recent
observation that PEX3 and PEX19 interact primarily at the
surface of the peroxisome membrane (Muntau et al., 2003).
The most widely accepted model of peroxisome biogenesis
is that peroxisomes are formed by the growth and division of
preexisting peroxisomes (Lazarow and Fujiki, 1985). Under
this model, any significant defect in PMP import would be
expected to cause the loss of peroxisomes from the cell. This
is precisely the phenotype of pex3- and pex19-null mutants
in both humans and S. cerevisiae (Matsuzono et al., 1999;
Hettema et al., 2000; Sacksteder et al., 2000; South et al.,
2000). Although class I PMP import might require more
protein factors than PEX19 and PEX3, it is also possible that
it does not. Therefore, we should not exclude additional
roles for PEX19 and PEX3 in PMP import. In fact, some
studies have detected interactions between class I PMPs and
both PEX19 and PEX3 at the peroxisome membrane (Sny-
der et al., 2000; Hazra et al., 2002) and these observations
might reflect a role for PEX3 and/or PEX19 in the insertion
of class I PMPs.
Neither PEX3 nor PEX19 are required for class II PMP
import (Jones et al., 2004). Of the PMPs that have been
tested, PEX3 is the only class II PMP yet identified. Given
the essential role for PEX3 in PMP import and the pheno-
types associated with the loss of PEX3 activity (loss of perox-
isomes from the cell, rapid destruction of PMPs, and cyto-
solic accumulation of matrix enzymes in the cytosol), it is
expected that loss of any factor involved in PEX3 import
would result in phenotypes that are at least as severe as the
pex3-null mutant. No such mutants are known in yeast but
the pex16 mutant of humans does meet these criteria. Future
studies that test whether PEX16 acts as a PEX3 import fac-
tor, as another class I PMP import factor, or as a critical
player in some other aspect of peroxisome membrane bio-
genesis (lipid import, peroxisome division, etc.) are a high
priority. In addition to searching for factors that might me-
diate PEX3 import, it might be possible that PEX3 does not
require any specific protein factors for import into peroxi-
somes, perhaps autocatalyzing its import into peroxisomes.
Interestingly, Haan et al. (2002) have observed that an engi-
neered epitope appears exposed to the cytosol regardless of
where it is inserted in PEX3, and on this basis have argued
that PEX3 might not even be an integral PMP, even though
it has the biochemical properties of being embedded in the
membrane.
The unique targeting pathway for PEX3 and its conserved
role in the import of most PMPs can also be interpreted in
the context of more speculative models of peroxisome bio-
genesis. For example, several researchers believe that peroxi-
somes arise, directly or indirectly, from the ER (Mullen et
al., 2001; Titorenko and Rachubinski, 2001a,b; Tabak et
al., 2003). A critical requirement of such models is the exist-
ence of a peroxin that is essential for the formation of perox-
isome membranes but traffics to peroxisomes by a mecha-
nism that is fundamentally distinct from that used by the
vast majority of PMPs. Moreover, Faber et al. (2002) have
claimed that the overexpression of nonfunctional forms of
PEX3 in a pex3-null mutant can stimulate the formation of
“preperoxisomal” vesicles from the ER and that these vesi-
cles subsequently mature into fully functional peroxisomes
upon the expression of WT PEX3. Our observation that
PEX3 is imported differently than most other PMPs might
be interpreted by some as indirect support for both an ER-
to-peroxisome route for PEX3 biogenesis and a direct role
for the ER in the genesis of peroxisomal vesicles.
Figure 8. Characterization of conditional pex3 mutants. A pex3-null 
strain that constitutively expresses CFP-PTS1 was transformed with 
plasmids that express the WT PEX3 allele (a–d), pex3-A8 allele (e–h), 
pex3-B5 allele (i–l), or pex3-G6 allele (m–p). The resulting strains 
were grown at either (a, b, e, f, i, j, m, and n) 25 C or (c, d, g, h, k, l, 
o, and p) 37 C for 3 d, fixed, and examined by phase contrast (a, c, 
e, g, i, k, m, and o) and epifluorescence microscopy specific for CFP 
(b, d, f, h, j, l, n, and p). Bar, 5  m.PEX3 acts as a docking factor in PMP import | Fang et al. 871
However, we do not feel that such a conclusion is war-
ranted at this time, and for several reasons. First, the kinetics
of PEX3-mediated peroxisome synthesis during the comple-
mentation of pex3-null mutants is one to two orders of magni-
tude slower than the kinetics of PEX3 import into peroxi-
somes of WT cells (South et al., 2000). This result means that
virtually all PEX3 is imported into preexisting peroxisomes
long before it even has the chance to mediate “de novo” per-
oxisome synthesis. These considerations raise serious doubts
as to whether any observations of peroxisome synthesis in the
absence of preexisting peroxisomes are physiologically rele-
vant. Second, the one study that has attempted to follow the
biogenesis of PEX3 in vivo found no evidence for PEX3 mi-
gration through the ER to the peroxisome in WT cells or in
cells that lack peroxisomes and instead detected PEX3 first in
the peroxisome (South et al., 2000). Third, PEX3-mediated
peroxisome synthesis occurs independently of the SEC61 and
SSH1 protein translocons in the ER membrane, indepen-
dently of the COPII coat complex, which is essential for vesic-
ular traffic from the ER, and independently of the COPI coat
complex, which is required for other vesicle-mediated traffick-
ing events in the early secretory pathway (South et al., 2001,
2000). These concerns and observations, coupled with the
unique function of PEX3 in peroxisome biogenesis and its
enigmatic route of import, make it more important than ever
to resolve the details of PEX3 biogenesis through direct analy-
sis of endogenously expressed PEX3 in normal cells.
Materials and methods
Plasmids
The plasmids pcDNA3-PMP34myc (Sacksteder et al., 2000), pcDNA3-
PEX11 myc (Schrader et al., 1998), pNHA-PTE1, pcDNA3-PMP34aa244–
307–3xmyc, pcDNA3–3xNLS-PEX19 and pcDNA3–3xNLS-HAOX3 (Jones
et al., 1999, 2001), pcDNA3-PEX3aa1–50–6xmet3xmyc, pcDNA3-
PEX16aa221–336–3xmyc, and pcDNA3-PMP22aa1–94–3xmyc (Jones et
al., 2004) have been described previously. pcDNA3-PEX3L125P/N134D-
3xmyc was generated by PCR PEX3aa83–139 (with CAGCAACTGAATT-
CCGAGAGCCTC, ATATCCACCAATTATGTCTAACTGGACCCGCAAAA-
GAACAACCGGCATAC) and PEX3aa135–232 (with CATAATTGGTG-
GATATATTTAC, AGGTTTGGATCCATCTTTATTAATC). Then, the two PCR
products were mixed and used as templates to do a second PCR (with CAG-
CAACTGAATTCCGAGAGCCTC, AGGTTTGGATCCATCTTTATTAATC).
The resultant PCR products were then digested with EcoRI and BamHI and
inserted into pcDNA3-PEX3–3xmyc digested with the same enzymes. The
rest of plasmids were created by amplifying DNA fragments with the indi-
cated primers (Table I), cleaving the fragments with restriction enzymes
able to cut the terminal palindromes on the fragments, and inserting the re-
sulting DNAs into the specified vectors. The plasmids pRS313-GAL1-
YFP-SKL, pRS313-GAL1-YFP-PEX10, pRS313-GAL1-YFP-PEX15, and pRS313-
GAL1-ANT1-YFP were generated by insertion of the GAL1 promoter
upstream of the YFP-tagged genes, and pRS315-PGK1-CFP-SKL was gener-
ated by insertion of the PGK1 promoter upstream of CFP-SKL. All PCR-gen-
Figure 9. The effect of PEX3 activity 
on PMP import. A pex3-null mutant that 
constitutively expresses CFP-PTS1 and 
(A) WT PEX3 allele or (B) pex3-G6 allele 
was transformed with plasmids designed 
to express (a–f) YFP-PTS1, (g–l) YFP-PEX10, 
(m–r) ANT1-YFP, or (s–x) YFP-PEX15 
under the control of galactose. The 
resulting strains were grown on minimal 
glucose medium at 25 C, transferred to 
minimal galactose medium, and main-
tained at (a–c, g–i, m–o, and s–u) 25 C, 
or shifted to (d–f, j–l, p–r, and v–x) 37 C 
for 2.5–4 h, followed by examination by 
phase contrast (a, d, g, j, m, p, s, and v), 
and epifluorescence microscopy specific 
for (b, e, h, k, n, q, t, and w) CFP and 
(c, f, i, l, o, r, u, and x) YFP. Bars, 5  m.872 The Journal of Cell Biology | Volume 164, Number 6, 2004
erated segments were sequenced in their entirety and only clones that pos-
sessed the correct sequence were used in the study.
Cell lines, immunofluorescence, and antibodies
The immortalized WT human skin fibroblast cell line (GM5756-TI) has
been described (Jones et al., 2004). The 3xHA-PEX19/PBD399-TI stable
cell line was generated by stably transfecting the immortalized PEX19-defi-
cient human cell line (PBD399-TI) (Jones et al., 2004) with NH2-terminally
tagged form of PEX19 (3xHA-PEX19), followed by selection with 300  g/
ml G418 (GIBCO BRL). All transfections were performed by electropora-
tion (Chang et al., 1997). For immunofluorescence, cells on cover glasses
were fixed with 3% formadehyde, permealized with 1% Triton X-100, and
incubated with primary antibodies for 30 min followed by extensive wash
with Dulbecco’s-modified PBS (GIBCO BRL), and then incubated with
FITC or Texas red-labeled secondary antibodies (Jackson ImmunoResearch
Laboratories) for 10 min followed by extensive washes, and mounted on
slides. The anti–c-myc monoclonal antibody, sheep anti-PMP70 antibod-
ies, rabbit anti-PEX3 antibodies (South et al., 2000), rabbit anti-PEX5
(Chang et al., 1999b), rabbit anti-PEX19, and anti-HAOX3 antibodies
(Jones et al., 2001) have been described previously. The polyclonal and
monoclonal antibodies against the HA epitope (Santa Cruz Biotechnology,
Inc.) and the HRP-labeled secondary antibodies (Jackson ImmunoResearch
Laboratories) were from commercial sources.
Immunofluorescence images were captured on a BH2-RFCA micro-
scope (Olympus) with an Olympus SplanApo 60x 0.40 oil objective and a
Sensicam QE (Cooke) digital camera using IPLab 3.6 software (Scanalytics)
at room temperature, and processed with Adobe Photoshop 7.0 software
(Adobe Systems, Inc.). Contrast, brightness, and gamma values were ad-
justed to approximate the original IPLab image.
SiRNA treatment and immunoblots
RNA oligonucleotides were obtained from Dharmacon Research, Inc. Four
pairs of RNA oligonucleotides were used in this study: PEX5: 5 -AGAAG-
CUACUCCCAAAGGCdTdT-3 , 5 -GCCUUUGGGAGUAGCUUCUdTdT-
3 ;  TRIP8b: 5’-GCAGGGAAAAGGCUCUAGGdTdT-3 , 5 -CCUAGAGC-
CUUUUCCCUGCdTdT-3 ;  PEX3: 5 -CGGACAGAUCCAUUCAGUUd-
TdT-3 , 5 -AACUGAAUGGAUCUGUCCGdTdT-3 ;  PEX16: 5 -UGACG-
GGAUCCUACGGAAGdTdT-3 , 5 -CUUCCGUAGGAUCCCGUCAdTdT-3 .
To test the effect of siRNA on protein levels, GM 5756-TI cells from each
confluent 75-cm
2 flask were suspended in 500  l Hepes-buffered saline
(21 mM Hepes, pH 7.15, 137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 6
mM dextrose), mixed with 50  l siRNA (20  M in annealing buffer: 100
mM KAc, 30 mM Hepes-KOH, pH 7.4, 2 mM MgAc), and electroporated
in a BTX ECM600 Electroporation System at 230 V, 1,500  F, 129 . After
transfection, cells were grown for 5 d. Every 24 h, cells were fixed with 3%
formaldehyde for indirect immunofluoresence study or lysed with SDS-
loading buffer for immunoblot study, respectively. An equal amount of to-
tal protein from each sample was subjected to SDS-PAGE gel. The proteins
were then transferred to PVDF membrane (Millipore), followed by incuba-
tion with primary antibodies and HRP-conjugated secondary antibodies
sequentially, and visualized by using ECL detection reagents (Amersham
Biosciences).
SiRNA treatment and peroxisomal protein import assay
GM5756-TI cells were transfected with PEX3, PEX5, and TRIP8b siRNAs
three times at 24-h intervals, respectively. At 72 h after the initial treat-
ment, cells were cotransfected with (a) pNHA-PTE1 and (b) pcDNA3-
PMP34myc, pcDNA3-PEX11 myc, pcDNA3-PEX16aa221–336–3xmyc, or
pcDNA3-PEX3aa1–50–6xmet3xmyc. 2 h after the DNA transfection, cells
were processed for double indirect immunofluoresence microscopy using
anti-myc and anti-HA antibodies. To quantify the import assay, all cells
showing peroxisomal staining (import of either marker) were counted as to
whether they imported HA-PTE1, PMP34myc (PEX11 myc, PEX3aa1–50-
6xmet3xmyc, PEX16aa221–336-3xmyc), or both. Each experiment was
done in triplicate and the mean and standard deviation were presented.
Yeast strains and screening for temperature-sensitive 
mutants of PEX3
The genotype of the S. cerevisiae strain BY4733 used in this study is
MATa, his3 200, leu2 0, met15 0, trp1 63, ura3 0. The YFY1 strain
was generated by one-step PCR-mediated disruption of PEX3 in BY4733
with URA3 as the selectable marker (Baker-Brachmann et al., 1998), fol-
Figure 10. The effect of other two conditional 
pex3 mutants on PMP import. A pex3-null mutant, 
which constitutively expresses CFP-PTS1 and (A) 
pex3-A8 allele or (B) pex3-B5 allele, was trans-
formed with plasmids designed to express (a–f) 
YFP-PTS1, or (g–l) YFP-PEX10 under the control 
of galactose. After being transferred to minimal 
galactose medium for 3 h at 25 C, the resultant 
strains were either maintained at (a–c and g–i) 
25 C, or shifted to (d–f and j–l) 37 C for four more 
hours, and examined by phase contrast (a, d, g, 
and j) and epifluorescence microscope specific for 
(b, e, h, and k) CFP and (c, f, i, and l) YFP. Bars, 5 
 m. (C) All cells with peroxisomal CFP-PTS1 were 
scored as to whether YFP was imported or not. 
Then the calculated percentage of import of each 
protein at 37 C was normalized to that at 25 C, 
respectively. Each experiment was done in triplicate 
and the mean and standard deviation are shown.PEX3 acts as a docking factor in PMP import | Fang et al. 873
lowed by transforming the cells with pRS315-PGK1-CFP-PTS1. To screen
for the temperature-sensitive mutants of PEX3, YFY1 cells were cotrans-
formed with the linearized gap repair plasmid pRS314-scPEX3UTR (di-
gested by SalI and NotI) and the error-prone PCR product of PEX3
flanked by 5  102 bps and 3  120 bps. Transformants were selected on
minimal S medium (0.17% yeast nitrogen base without ammonium sul-
fate [Sigma-Aldrich], 0.5% ammonium sulfate) with 2% glucose lacking
uracil, leucine, and tryptophan. Each transformant was spotted onto du-
plicate plates, which were then incubated at 25  and 37 C for 3 d, and
then examined by epifluorescence microscopy to determine the subcel-
lular distribution of CFP-PTS1. Those that imported CFP-PTS1 at 25 C but
accumulated CFP-PTS1 in the cytoplasm at 37 C were considered tem-
perature-sensitive mutants of PEX3.
PMP import assay in WT and pex3
ts strains
The YFY1 strain was transformed with pRS314-PEX3 as WT control for
pex3
ts strains. Next, the WT and pex3
ts strains, which constitutively ex-
pressed CFP-PTS1, were retransformed with the plasmids: pRS313-
GAL1-YFP-PTS1, pRS313-GAL1-YFP-PEX10, pRS313-GAL1-ANT1-YFP,
pRS313-GAL1-YFP-PEX15. The YFP-tagged peroxisomal proteins were
expressed under the control of the galactose-inducible GAL1 promoter.
Cells were grown at 25 C on minimal glucose medium lacking uracil,
leucine, histidine, and tryptophan to repress expression of the YFP
marker proteins. For the import assay of YFP-PTS1, YFP-PEX10, YFP-
PEX15, pex3-WT, and pex3-G6 cells were transferred to minimal me-
dium with 2% galactose at 25 C for 2–3 h, and then either maintained at
25 C or shifted to 37 C for four more hours. For the import assay of
ANT1-YFP, pex3-WT and pex3-G6 cells grown in glucose minimal me-
dium were shifted to 37 C for 2.5 h, and then transferred to minimal ga-
lactose (2%) medium for two and a half more hours. For the import as-
say of YFP-PTS1 and YFP-PEX10 in pex3-A8 and pex3-B5 strains, cells
were transferred to minimal galactose medium at 25 C for 2–3 h, and
then either maintained at 25 C or shifted to 37 C for four more hours.
Cells with CFP-PTS1 imported to peroxisome were scored as to whether
YFP imported or not. Then the calculated percentage of import of each
protein at 37 C was normalized to that at 25 C, respectively. Each ex-
periment was performed in triplicate and the mean and standard devia-
tion are presented.
Table I. Primers used
Plasmid Primers Vectors
PEX3-3xmyc 5 CCGGTACCATGCTGAGGTCTGTATGGAATTTTCTG
3 CCAGATCTTTTCTCCAGTTGCTGAGGGGTAC
pcDNA-(C)3xmyc
3xmyc-PEX3aa50-373 5 CCGTCGACCGCCCAAGCACGACGACAATATCATTTTG
3 CCGCGGCCGCTCATTTCTCCAGTTGCTGAGGGGTAC
pcDNA3-(N)3xmyc
3xmyc-PEX3aa1-100 5 CCCTCGAGCCTGAGGTCTGTATGGAATTTTCTG
3 CCGCGGCCGCTCACTTGTTTGAAGGCCTGTTTTTTAGCAG
pcDNA3-(N)3xmyc
3xmyc-PEX3aa1-148 5 CCCTCGAGCCTGAGGTCTGTATGGAATTTTCTG
3 CCGCGGCCGCTCAGCCAACTGCTGCATTATC
pcDNA3-(N)3xmyc
3xmyc-PEX3aa100-148 5 CCCTCGAGCAAGCTAGAAATATGGGAGGATC
3 CCGCGGCCGCTCAGCCAACTGCTGCATTATC
pcDNA3-(N)3xmyc
3xmyc-PEX3aa120-140 5 CCCTCGAGCTACAGTACCTGTATGCTGGTTG
3 CCGCGGCCGCTCAAATATATCCACCAATTATGTTTAACTG
pcDNA3-(N)3xmyc
3xmyc-PEX3aa120-136 5  CCCTCGAGCTACAGTACCTGTATGCTGGTTG
3 CCGCGGCCGCTCAAATTATGTTTAACTGGACCCGC
pcDNA3-(N)3xmyc
3xmyc-PEX3aa121-136 5 CCCTCGAGCAGTACCTGTATGCTGGTTGTTC
3 CCGCGGCCGCTCAAATTATGTTTAACTGGACCCGC
pcDNA3-(N)3xmyc
3xmyc-PEX3aa120-135 5 CCCTCGAGCTACAGTACCTGTATGCTGGTTG
3 CCGCGGCCGCTCATATGTTTAACTGGACCCGCAAAAG
pcDNA3-(N)3xmyc
pcDNA3-3xNLS 5 CCCAAGCTTGCCATGGCATGTCCAAAG
3 CCGGTACCATCACCGACTTTCCGTTTCTTC
pcDNA3
3xNLS-PEX19aa1-56-3xHA 5 CCGGTACCGCCGCCGCTGAGGAAGGCTGTAG
3 CCGGATCCTCCTGGCGATCTCTTCTGGGG
pcDNA3-
(N)3xNLS
3xNLS-PEX19aa57-299-3xHA 5 CCGGTACCGACACTGCCAAAGATGCCCTCTTC
3 CCGGATCCCATGATCAGAACACTGTTCACCAC
pcDNA3-
(N)3xNLS
3XHA-PEX19 5 CCCTCGAGCGCCGCCGCTGAGGAAGGCTGTAG
3 CCGCGGCCGCTCACATGATCAGACACTGTTCACC
pcDNA3-
(N)3xHA
3xHA-PEX19aa1-56 5 CCCTCGAGCGCCGCCGCTGAGGAAGGCTGTAG
3 CCGCGGCCGCTCATCCTGGCGATCTCTTCTG
pcDNA3-
(N)3xHA
3xHA-PEX19aa57-299 5 CCCTCGAGCGACACTGCCAAAGATGCCCTCTTC
3 CCGCGGCCGCTCACATGATCAGACACTGTTCACC
pcDNA3-(N)3xHA
scPEX3 5 CGCCTCGAGCGGCATCTGAATCTACAGAGGTGG
3 CGCCCGCGGTCACAATCTCGTCGTCATCCTCATC
pRS314
scPEX3UTR 5 CGCCTCGAGCGGCATCTGAATCTACAGAGGTGG
3 CGCGGATCCGTCGACATCCTTTTAGTGGTTTGCCTCCTTG
5 CGCGGATCCGCGGCCGCTCTCTGAATAAGTACTGACACTCACAC
3 CGCCCGCGGTCACAATCTCGTCGTCATCCTCATC
pRS314
pRS313-(N)YFP 5 CCAAGGATCCATGGTGAGCAAGGGCGAGGAG
3 CCCCTCGAGTTCTTGTACAGCTCGTCCATGCC
pRS313
YFP-scPEX10 5 CAAGTCGACGAAGAATGATAATAAGTTGCAAAAGGAAGC
3 CCAAGCGGCCGCTATTGCCGCAGGACCAGAATTTC
pRS313-(N)YFP
YFP-scPEX15 5 CCAAGCGGCCGCATTGGTTGGACACGGTTAC
3 CAAGTCGACGGCTGCAAGTGAGATAATG
pRS313-(N)YFP
pRS313-(C)YFP 5 CCCGCGGCCGCAGTGAGCAAGGGCGAGGAGCTGTTC
3 CCCCCGCGGTTACTTGTACAGCTCGTCCATGCC
pRS313
ANT1-YFP 5 GGGGGATCCCATGTTAACTCTAGAGTCTGCATTAAC
3 CCTGCGGCCGCAGTGGAAGCCAGCTTGCGTTGTCCGTG
pRS313-
(C)YFP
YFP-SKL and 
CFP-SKL
5 CCAAGGATCCATGGTGAGCAAGGGCGAGGAG
3 CCCTCTAGATCACAGCTTCGACTTGTACAGCTCGTCCATGCC
pRS313
pRS315874 The Journal of Cell Biology | Volume 164, Number 6, 2004
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